期刊文献+

高血压房颤与孤立性房颤的临床对比分析 被引量:1

of clinical features of hypertension fibrillation and lone atrial fibrillation
下载PDF
导出
摘要 目的:分析高血压房颤(HAF)与孤立性房颤(LAF)的临床特征及其对预后的影响。方法:高血压房颤患者106例,孤立性房颤患者102例,分别对其性别,年龄,家族史,并发症,持续性房颤发生情况,超声心动图等临床特征进行分析。结果:二者相比,LAF组发病年龄轻,左房增大者少,持续性房颤者少;两组中左房增大均与持续性房颤者,并发症呈正相关。高血压程度与持续性房颤者,并发症呈正相关。结论左房增大是房颤发生的主要机制,左房是否增大是判断愈后的一个重要指标。 Objective: To analyse the clinical features and their prognoses of hypertension atrial fibrillation(HAF) and lone atrial fibrillation(LAF). Methods: One hundred and six patients with HAF and One hundred and two patients with LAF were selected,Clinical data of all the patients were studied. Results: Compared with HAF group, lower onset ages, less left atrial dilation(LAD), persistent atrial fibrillation(PAF) and complication were in LAF group. In the two groups, LAD was positively related with PAF and complication, so was the degree of hyperten sion. Conclusions: Left atrial dilation was one of the most important reason of atrial fibrillation, which was an important predictor of prognosis.
出处 《现代生物医学进展》 CAS 2006年第10期84-85,共2页 Progress in Modern Biomedicine
关键词 高血压房颤 孤立性房颤 临床特征 预后 Hypertension atrial fibrillation Lone atrial fibrillation Clinical features Prognosis
  • 引文网络
  • 相关文献

参考文献8

  • 1Petersen P,Godtfendsen J.Atrial fibrillation:A review of course and prognosis[J].Acta Med Scand,1984,216(1):5-9
  • 2Cha TJ,Ehrlich JR,Zhang L,et al.Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure[J].Circulation,2004,109(3):412-8
  • 3Benjamin EJ,D Agostino RB,Belanger AJ,et al.Left atrial size and the risk of stroke and death.the Framingham heart study[J].Circulation,1995,92(4):835-841
  • 4Sanfilippo AJ,Abascal V M,Sheehan M,et al.Atrial enlargement as a consequence of atrial fibrillation:a prospecyive echocardiographic study[J].Circulation,1990,82(3):792-797
  • 5Sasa G,Lampert S,Ravid S,et al.Changes in left atrial size in patients with lone atrial fibrillation[J].Clin Cardiol,1991,14(8):652-656
  • 6Darbar D,Herron KJ,Ballew JD,et al.Familial atrial fibrillation is agenetically heterogeneous disorder[J].Am Coll Cardiol,2003,41(12):2185 -2192
  • 7Ellinor PT,Shin JT,Moore RK,et al.Locus for atrial fibrillation maps to chromosome 6q14-16[J].Circulation,2003,107(23):2880
  • 8Maixent J M,Paganelli F,Scaglione,et al.Antibodies against myosin in sera of patients with diopathic paroxysmal atria; fibrillation[J].Cardiovasc electrophysiol,1998,9(6):612-617

同被引文献14

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1402
  • 2Nakashima H, Kumagai K, Urata H, et al. Angiotensin II antagonist prevents electrical remodeling in atrial fribrillation [J]. Circulation, 2000,104(22):2612- 2617.
  • 3Madrid AH, BuenoMG, Rebllo JMc, et al. Use ofirbesartan tomaintain sinus rhythm in patients with long - lasting persistent atrial fibrillation a prospective, and randomized Study[J]. Circulation, 2002,106:331-336.
  • 4Nergrdh AK, Rosenqvist M, Frick M. Self-limited bursts of atrial fibrillation following successful cardioversion.Int J Cardiol, 2007,19(1): 95-100.
  • 5Madrid AH, Escobar C, Rebollo JM, et al. Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial[J]. Card Electrophysiol Rev, 2003,7 (3):243-246.
  • 6Madrid AH, Mari n IM, Cervantes CE, et al.Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers [J]. J Renin Angiotensin Aldosterone Syst, 2004, 5(3):114-120.
  • 7Ueng KC, Tsai TP, Yu WC, et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study[J]. Eur Heart J, 2003, 24(23):2090-2098.
  • 8Capucei A, Villani GQ, Aschieri D, et al. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation [J]. Eur Heart J, 2000, 21(1):66-73.
  • 9Singh BN, Singh SN, Reda DJ, et al. Amiodarone versus sotalol for atrial fibrillation[J]. N Engl J Med, 2005, 352(18):1861-1872.
  • 10HideKo N, koiekirok,HidenoriU, et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation [J]. circulation, 2002, 101:2612-2617.

引证文献1

;
使用帮助 返回顶部